Fred and Pamela Buffett Cancer Center - Kearney — Kearney, Nebraska

Fred and Pamela Buffett Cancer Center - Kearney is a clinical research site located in Kearney, Nebraska, United States 68845.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Fred and Pamela Buffett Cancer Center - Kearney has participated in 46 clinical trials with 38 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Endometrial Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), NRG Oncology, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fred and Pamela Buffett Cancer Center - Kearney?

Fred and Pamela Buffett Cancer Center - Kearney has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fred and Pamela Buffett Cancer Center - Kearney conducted?

Fred and Pamela Buffett Cancer Center - Kearney has 46 clinical trials on record, with 38 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Endometrial Adenocarcinoma.

Is Fred and Pamela Buffett Cancer Center - Kearney accredited by Crixeo Health?

Fred and Pamela Buffett Cancer Center - Kearney has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fred and Pamela Buffett Cancer Center - Kearney?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.